SpeechVive
Latest round
- Series A
Last raised
- Apr 2014
Total raised
- $0.7M
Investors
- 1
About SpeechVive
SpeechVive Inc.SpeechVive Inc. was founded in 2011 in Lafayette, US. The company develops wearable devices that assist individuals with Parkinson's disease in enhancing their speech capabilities.98 mn.SpeechVive specializes in the development and distribution of a wearable speech device designed specifically for individuals with Parkinson’s disease. This innovative product functions by automatically triggering the brain to enhance speech volume, clarity, and pacing during verbal communication. The primary use case for SpeechVive is to improve the quality of life for patients by facilitating easier and more effective conversations, thereby reducing the stress often associated with speech difficulties. The device eliminates the need for intensive therapy, serving as an alternative to traditional behavioral treatment programs that can last for several weeks. The target clientele includes Parkinson's patients, their caregivers, and healthcare providers, particularly speech-language pathologists.SpeechVive generates revenue through direct sales of its wearable speech devices to patients and healthcare professionals, as well as partnerships with Medicare, the Veterans Administration, and various commercial insurance plans. The company's transaction structure includes direct-to-consumer sales, where individuals purchase the SpeechVive device either through online channels or healthcare providers. The pricing model typically involves a one-time purchase of the device, which may be covered partially or fully by insurance providers. The flagship product, the SpeechVive device, is tailored to deliver immediate results in improving speech functionality for users, promoting enhanced communication in both personal and professional settings.In August 2018, SpeechVive Inc. The company plans to enhance its product offerings designed for individuals with speech difficulties, focusing on innovative features that augment user experience. Additionally, SpeechVive is targeting expansion into international markets to reach a broader audience, although specific regions and timelines have not been disclosed.
Who invested in SpeechVive
1 investor across 1 round
See all investors in SpeechVive
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 4, 2014
Amount
$0.7M
Investors
Questions about SpeechVive
Who invested in SpeechVive?
SpeechVive has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SpeechVive raised?
SpeechVive has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SpeechVive last raise money?
SpeechVive's most recent round on record is a Series A, in Apr 2014.
What does SpeechVive do?
SpeechVive is a medical devices & equipment company.
Where is SpeechVive headquartered?
SpeechVive is headquartered in Lafayette, US.
Which VCs invest in companies like SpeechVive?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at SpeechVive's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like SpeechVive? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.